logo
logo
  • Home
  • Product
    • How it works
    • Resources
    • Patients
  • AI Solution
  • Clinical
    • Scientific publications
    • SBI 2021
    • RSNA 2021
      • Use of Prior Mammogram by MammoScreen Can Help Reduce False Positives
      • MammoScreen Helps Improve Performance and Efficiency in 3D Screenings
  • News & Events
    • Blog
    • Press
  • About
    • FAQ
  • Contact

Press

Discover what the Press says about Mammosceen® 2D&3D

Concurrent use of AI helps radiologists on mammography-Aunt Minnie
mammography-breast-cancer-screening-gets-boost-from-ai-clinical-omics-5-11-2020
Mammography AI Tool Cleared This Year Improves Breast Cancer Detection _ Diagnostic Imaging
AI-Powered-Reading-Increases-Mammography-Accuracy-artificial-intelligence-Hospimedica.co
Paris-based-Therapixel-scores-FDA-clearance-for-breast-image-reading-assistant-Radiology-Business
The Exciting Future of AI and Mammography - and Physicians _ Imaging Technology News
MammoScreen® is a product of:
Therapixel

MammoScreen® is a registered trademark of Therapixel Inc.

Menu
  • Product
  • AI Solution
  • Clinical
  • News
  • About
  • FAQ
  • Contact

Extras
  • Legal info
  • Privacy Policy
  • Sitemap

MammoScreen® is 510(k) FDA cleared for FFDM (2D) and DBT (3D).

Request a demo
Contact
1700 W Irving Park Road ST. 302
Chicago – IL 60613
USA

© 2021 Therapixel | Web design by Domaine-Pack.fr

Privacy Preference Center

Privacy Preferences